Ischaemic tolerance: A window to endogenous neuroprotection?

Lancet

Volumn 362, Issue 9389, 2003, Pages 1007-1008

  Schaller, Bernhard ^a   Graf, Rudolf ^a   Jacobs, Andreas H ^a,b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b Department of Neurology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEAT SHOCK PROTEIN 70; ISOFLURANE; NEUROPROTECTIVE AGENT; POTASSIUM CHANNEL STIMULATING AGENT;

APOPTOSIS; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; BRAIN ISCHEMIA; CELL DAMAGE; CEREBELLUM; CONDITIONING; DEPRESSION; GENE EXPRESSION; GENE TARGETING; HUMAN; HYPERBARISM; HYPERTHERMIA; HYPOTHERMIA; HYPOXIA; INFLAMMATION; METABOLIC INHIBITION; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SEIZURE;

EID: 0141537240     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14446-7     Document Type: Note

References (13)

1. Schaller B., Graf R. Cerebral ischemic preconditioning: an experimental phenomenon or clinical important entity of stroke prevention? J Neurol. 11:2002;1503-1511.
2. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26:2003;248-254.
3. Moncayo J., deFreitas G.R., Bogousslavsky J., Altieri M., van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology. 54:2000;2089-2094.
4. Hadjikhani N., Sanchez Del Rio M., Wu O., et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 98:2001;4687-4692.
5. Bickler P.E., Donohoe P.H., Buck L.T. Molecular adaptations for survival during anoxia: lessons from lower vertebrates. Neuroscientist. 8:2002;234-242.
6. Prass K., Ruscher K., Kursch M., et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab. 22:2002;520-525.
7. Kapinya K.J., Lowl D., Futterer C., et al. Tolerance against ischemic neuronal injury can be induced by volatile anaesthetics and is inducible NO synthase dependent. Stroke. 33:2002;1889-1898.
8. Shimizu K., Lacza Z., Rajapakse N., Horiguchi T., Snipes J., Busija D.W. MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. Am J Physiol Heart Circ Physiol. 283:2002;H1005-H1011.
9. Fisher M., Ratan R. New perspectives on developing acute stroke therapy. Ann Neurol. 53:2003;10-20.
10. DeGracia D.J., Kumar R., Owen C.R., Krause G.S., White B.C. Molecular pathways of protein synthesis inhibition during brain reperfusion. J Cereb Blood Flow Metab. 22:2002;393-403.
11. Yenari M.A., Fink S.L., Sun G.H., et al. Gene therapy with Hsp72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol. 44:1998;584-591.
12. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 333:1995;1581-1587.
13. Heiss W.D., Grond M., Thiel A., von Stockhausen H.M., Rudolf J. Ischaemic brain tissue salvaged from infarction with alteplase. Lancet. 349:1997;1599-1600.